Estrogen-induced genes in the uterus of ovariectomized rats and their regulation by droloxifene and tamoxifen

Journal of Steroid Biochemistry and Molecular Biology

Volumn 64, Issue 1-2, 1998, Pages 13-24

  Rivera Gonzalez, Ramon ^a   Petersen, Donna N ^a   Tkalcevic, George ^a   Thompson, David D ^a   Brown, Thomas A ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; DROLOXIFENE; ESTROGEN; ETHINYLESTRADIOL; HEAT SHOCK PROTEIN 70; INOSITOL PHOSPHATE; INTERLEUKIN 4 RECEPTOR; MESSENGER RNA; METALLOTHIONEIN; SYNAPSIN II; SYNTHETASE; TAMOXIFEN; TUMOR NECROSIS FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA LIBRARY; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC MARKER; HYBRIDIZATION; NONHUMAN; NORTHERN BLOTTING; ORAL DRUG ADMINISTRATION; OVARIECTOMY; POLYMERASE CHAIN REACTION; QUANTITATIVE ASSAY; RAT; RNA ANALYSIS; SEXUAL DEVELOPMENT; UTERUS;

ANIMALS; BASE SEQUENCE; DNA, COMPLEMENTARY; ESTROGEN ANTAGONISTS; ETHINYL ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; MOLECULAR SEQUENCE DATA; MYO-INOSITOL-1-PHOSPHATE SYNTHASE; OVARIECTOMY; OVARY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID; TAMOXIFEN; TISSUE DISTRIBUTION; UTERUS;

EID: 0031888998     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(97)00142-8     Document Type: Article

References (50)

1. Parker M. G. Structure and function of estrogen receptors. Vit. Horm. 51:1995;267-287.
2. Chalbos D., Philips A., Rochefort H. Genomic cross-talk between the estrogen receptor and growth factor regulatory pathways in estrogen target tissues. Semin. Cancer Biol. 5:1994;361-368.
3. Umayahara Y., Kawamori R., Watada H., Imano E., Iwama N., Morishama T., Yamasaki Y., Kajimoto Y., Kamada T. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J. Biol. Chem. 269:1994;16433-16442.
4. Gaub M. P., Bellard M., Scheuer I., Chambon P., Sassone C. P. Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex. Cell. 63:1990;1267-1276.
5. Stein B., Yang M. X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ Mol. Cell. Biol. 15:1995;4971-4979.
6. Kuiper G. G. J. M., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J. A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5925-5930.
7. Lobo R. A. Benefits and risks of estrogen replacement therapy. Am. J. Obstet. Gynecol. 173:1995;982-990.
8. Hammond C. B. Menopause and hormone replacement therapy: An overview. Obstet. Gynecol. 87:1996;2S-15S.
9. Schwartz J., Freeman R., Frishman W. Clinical pharmacology of estrogens: Cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women. J. Clin. Pharmacol. 35:1995;1-16.
10. Paganini-Hill A., Henderson V. W. Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140:1994;256-261.
11. Love R. R., Mazess R. B., Barden H. S., Epstein S., Newcomb P. A., Jordan V. C., Carbone P. P., DeMets D. L. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. New Engl. J. Med. 326:1992;852-856.
12. Nayfield S. G., Karp J. E., Ford L. G., Dorr F. A., Kramer B. S. Potential role of tamoxifen in prevention of breast cancer. J. Natl. Cancer Inst. 83:1991;1450-1459.
13. Kedar R. P., Bourne T. H., Powless T. J., Collins W. P., Ashley S. E., Cosgrove D. O., Campbell S. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet. 343:1994;1318-1321.
14. Hasmann M., Rattel B., Loser R. Preclinical data for droloxifene. Cancer Lett. 84:1994;101-116.
15. Ke H. Z., Simmons H. A., Pirie C. M., Crawford D. T., Thompson D. D. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats. Endocrinology. 136:1995;2435-2441.
16. Ke H. Z., Chen H. K., Simmons H. A., Qi H., Crawford D. T., Pirie C. M., Chidsey-Frink K. L., Ma Y. F., Jee S. S., Thompson D. D. Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model. Bone. 20:1997;31-39.
17. Maniatis, T., Fritsch, E. F. and Sambrook, J., Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Lab., Cold Spring Harbor, New York, 1982.
18. Wang Z., Brown D. D. A gene expression screen. Proc. Natl. Acad. Sci. U.S.A. 88:1991;11505-11509.
19. Lisitsyn N., Lisitsyn N., Wigler M. Cloning the differences between two complex genomes. Science. 259:1993;946-951.
20. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
21. Delorme A. C., Danan J. L., Acker M. G., Ripoche M. A., Mathieu H. In rat uterus 17β-estradiol stimulates a calcium-binding protein similar to the duodenal vitamin D-dependent calcium-binding protein. Endocrinology. 113:1983;1340-1347.
22. L'Horset F., Perret C., Brehier A., Thomasset M. 17β-estradiol stimulates the calbindin-D9k (CaBP9k) gene expression at the transcriptional and posttranscriptional levels in the rat uterus. Endocrinology. 127:1990;2891-2897.
23. L'Horset F., Blin C., Colnot S., Lambert M., Thomasset M., Perret C. Calbindin-D9k gene expression in the uterus: Study of the two messenger ribonucleic acid species and analysis of an imperfect estrogen-responsive element. Endocrinology. 134:1994;11-18.
24. Darwish H., Krisinger J., Furlow J. D., Smith C., Murdoch F. E., DeLuca H. F. An estrogen-responsive element mediates the transcriptional regulation of calbindin D-9k gene in rat uterus. J. Biol. Chem. 266:1991;551-558.
25. Sundstrom S. A., Komm B. S., Ponce-de-Leon H., Yi Z., Teuscher C., Lyttle C. R. Estrogen regulation of tissue-specific expression of complement C3. J. Biol. Chem. 264:1989;16941-16947.
26. Tang P. Z., Gannon M. J., Andrew A., Miller D. Evidence for oestrogenic regulation of heat shock protein expression in human endometrium and steroid-responsive cell lines. Eur. J. Endocrinol. 133:1995;598-605.
27. Koshiyama M., Konishi I., Nanbu K., Nanbu Y., Mandai M., Komatsu T., Yamamoto S., Mori T., Fujii S. Immunohistochemical localization of heat shock proteins HSP70 and HSP90 in the human endometrium: Correlation with sex steroid receptors and Ki-67 antigen expression. J. Clin. Endocrinol. Metab. 74:1995;724-731.
28. Webb D. K., Moulton B. C., Khan S. A. Estrogen induces expression of c-jun and jun-B protooncogenes in specific rat tissues. Endocrinology. 133:1993;20-28.
29. Dean-Johnson M., Henry S. A. Biosynthesis of inositol in yeast: Primary structure of myo-inositol-1-phosphate synthase (EC 5.5.1.4) and functional analysis of its structural gene, the INO1 locus. J. Biol. Chem. 264:1989;1274-1283.
30. Klig L. S., Zobel P. A., Devry C. G., Losberger C. Comparison of INO1 gene sequences and products in Candida albicans and Saccharomyces cerevisiae. Yeast. 10:1994;789-800.
31. Kaye A. M., Sheratzky D., Lindner H. R. Kinetics of DNA synthesis in immature rat uterus: Age dependence and estradiol stimulation. Biochim. Biophys. Acta. 261:1972;475-486.
32. Kirkland J. L., LaPointe L., Justin E., Stancel G. Effect of estrogen on mitosis in individual cell types of the immature rat uterus. Biol. Reprod. 21:1979;269-272.
33. Pollard J. W. Regulation of polypeptide growth factor synthesis and growth factor-related gene expression in the rat and mouse uterus before and after implantation. J. Reprod. Fertil. 88:1970;721-731.
34. Clark B. F. The effect of estrogen and progesterone on uterine cell division and epithelial morphology in spayed, adrenalectomized rats. J. Endocrinol. 50:1971;527-528.
35. Pratt W. B. Control of steroid-receptor function and cytoplasmic-nuclear transport by heat-shock proteins. Bioassays. 14:1992;841-848.
36. Smith D. F., Toft D. O. Steroid receptors and their associated proteins. Mol. Endocrinol. 7:1993;4-11.
37. Weisz A., Bresciani F. Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus. Mol. Endocrinol. 2:1988;816-824.
38. Berridge M. J. Inositol triphosphate and calcium signalling. Nature. 361:1993;315-325.
39. Maeda T., Eisenberg F. Purification, structure, and catalytic properties of 1-myo-inositol-1-phosphate synthase from rat testis. J. Biol. Chem. 255:1980;8458-8464.
40. Hamer D. H. Metallothionein. Ann. Rev. Biochem. 55:1986;913-951.
41. Ebadi M., Iversen P. L. Metallothionein in carcinogenesis and cancer chemotherapy. Gen. Pharmacol. 25:1994;1297-1310.
42. O'Brien T. P., Yang G. P., Sanders L., Lau L. F. Expression of cyr61, a growth factor-inducible immediate-early gene. Mol. Cell. Biol. 10:1990;3569-3577.
43. Yang G. P., Lau L. F. Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface. Cell Growth Diff. 2:1991;351-357.
44. Kireeva M. L., Mo F. -E., Yang G. P., Lau L. A. Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration and adhesion. Mol. Cell. Biol. 16:1996;1326-1334.
45. DeAngelo A. B., Gorski J. Role of RNA synthesis in the estrogen induction of a specific uterine protein. Proc. Natl. Acad. Sci. U.S.A. 66:1970;693-700.
46. Henrikson K. P., Jazin E. E., Greenwood J. A., Dickerman H. W. Prothrombin levels are increased in the estrogen-treated immature rat uterus. Endocrinology. 126:1990;167-175.
47. Tchernitchin A., Roorijck J., Tchernitchin X., Vandenhende J., Galand P. Dramatic early increase in uterine eosinophils after estrogen administration. Nature. 248:1974;142-143.
48. Lee T. H., Klampfer L., Shows T. B., Vilcek J. Transcriptional regulation of TSG6, a tumor necrosis factor- and interleukin-1-inducible primary response gene coding for a secreted hyaluronan-binding protein. J. Biol. Chem. 268:1993;6154-6160.
49. Robinson S. P., Langan-Fahey S. M., Johnson D. A., Jordan V. C. Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metabol. Deposit. 19:1991;36-43.
50. Tanaka T., Sekiguchi M., Sawamoto T., Hata T., Esumi Y., Sugai S., Ninomiya S. Pharmacokinetics of droloxifene in mice, rats, monkeys, premenopausal and postmenopausal patients. Eur. J. Drug Metabol. Pharmacokin. 19:1994;47-58.